Krystal Biotech Inc Working Capital to Net Assets Ratio
Krystal Biotech Inc working capital to net assets ratio. Krystal Biotech Inc (KRYS) has a Working Capital to Net Assets ratio of 68.6% as of June 2026. Working capital of $932.25 Million (current assets of $1.06 Billion minus current liabilities of $127.40 Million) is measured against net assets of $1.36 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check KRYS tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Krystal Biotech Inc (2016–2025)
Working capital to net assets ratio of Krystal Biotech Inc from 2016 to 2025. This chart shows how Krystal Biotech Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 68.6%, reflecting working capital of $932.25 Million against net assets of $1.36 Billion USD. See Krystal Biotech Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Krystal Biotech Inc Working Capital to Net Assets Ratio by Year (2016–2025)
Krystal Biotech Inc working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Krystal Biotech Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see KRYS asset base.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 75.6% | $921.66 Million | $1.22 Billion | $1.02 Billion | $102.94 Million | ▲ +7.9 pp |
| 2024 | 67.6% | $640.05 Million | $946.38 Million | $742.04 Million | $102.00 Million | ▼ -3.6 pp |
| 2023 | 71.3% | $554.82 Million | $778.64 Million | $587.91 Million | $33.09 Million | ▲ +3.3 pp |
| 2022 | 68.0% | $354.93 Million | $522.23 Million | $383.78 Million | $28.85 Million | ▼ -2.2 pp |
| 2021 | 70.2% | $416.53 Million | $593.58 Million | $442.27 Million | $25.74 Million | ▼ -18.7 pp |
| 2020 | 88.9% | $259.61 Million | $292.08 Million | $275.06 Million | $15.45 Million | ▼ -6.0 pp |
| 2019 | 94.9% | $192.55 Million | $202.91 Million | $195.88 Million | $3.33 Million | ▼ -2.3 pp |
| 2018 | 97.2% | $110.05 Million | $113.23 Million | $112.65 Million | $2.60 Million | ▼ -2.4 pp |
| 2017 | 99.6% | $49.27 Million | $49.47 Million | $49.91 Million | $640.00K | ▼ -636.0 pp |
| 2016 | 735.6% | $2.13 Million | $289.00K | $2.17 Million | $43.00K | — |